Based on the published research, including multiple systematic reviews and meta-analyses, the answer for healthy individuals is generally yes. GR-1™ and RC-14™, the strains in Bio-K+ Women’s Health Capsules, have been clinically studied in pregnant women, with no serious adverse events reported. This applies specifically to these strains. Always consult your healthcare practitioner before starting any new product during pregnancy.

Lactobacillus and Bifidobacterium species are the most widely researched genera in pregnancy contexts. GR-1™ and RC-14™ are the world’s most documented probiotics combination for women’s urogenital health, backed by 60+ scientific publications and more than 25 clinical trials. These strains have been clinically studied in pregnant women, with no serious adverse events reported. Consult your healthcare practitioner for strain-specific guidance appropriate to your situation.

The published research on probiotics in the first trimester and across pregnancy broadly supports their general safety for healthy individuals, based on available systematic reviews. Bio-K+ Women’s Health Capsules are intended for adults and adolescents aged 12 and older, with no trimester restrictions. Consult your healthcare practitioner for guidance specific to your trimester and individual health needs.

Confirm strain codes are listed by name, such as GR-1™ and RC-14™, not just the genus. Verify the CFU count is guaranteed until the expiration date, not only at manufacture. Check certifications such as gluten-free and non-GMO. Discuss your probiotic choice with your healthcare practitioner before starting.

GR-1™ and RC-14™ in Women’s Health Capsules have been clinically studied in various female populations, with no serious adverse events reported. The label directions apply to adults and adolescents 12 years and older, with no exclusion for breastfeeding. Consult your healthcare practitioner for guidance specific to your individual health situation during breastfeeding.